TEVA

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Dollar change +0.25
Percentage change 1.56	%

Index	-	P/E	-	EPS (ttm)	-0.42	Insider Own	0.01%	Shs Outstand	1.12B	Perf Week	16.24%
Market Cap	18.22B	Forward P/E	6.02	EPS next Y	2.70	Insider Trans	-85.80%	Shs Float	1.12B	Perf Month	17.16%
Income	-461.00M	PEG	-	EPS next Q	0.59	Inst Own	51.04%	Short Float	1.09%	Perf Quarter	35.30%
Sales	16.02B	P/S	1.14	EPS this Y	-5.32%	Inst Trans	9.28%	Short Ratio	1.23	Perf Half Y	77.60%
Book/sh	6.43	P/B	2.53	EPS next Y	11.36%	ROA	-1.07%	Short Interest	12.22M	Perf Year	94.61%
Cash/sh	2.67	P/C	6.09	EPS next 5Y	1.60%	ROE	-6.08%	52W Range	7.09 - 16.25	Perf YTD	55.65%
Dividend Est.	-	P/FCF	7.83	EPS past 5Y	26.63%	ROI	-1.91%	52W High	0.00%	Beta	0.89
Dividend TTM	-	Quick Ratio	0.61	Sales past 5Y	-2.68%	Gross Margin	49.00%	52W Low	129.36%	ATR (14)	0.51
Dividend Ex-Date	Nov 27, 2017	Current Ratio	0.89	EPS Y/Y TTM	71.44%	Oper. Margin	20.90%	RSI (14)	80.17	Volatility	4.42% 3.30%
Employees	37226	Debt/Eq	2.74	Sales Y/Y TTM	7.21%	Profit Margin	-2.88%	Recom	2.15	Target Price	17.88
Option/Short	Yes / Yes	LT Debt/Eq	2.32	EPS Q/Q	32.68%	Payout	-	Rel Volume	1.39	Prev Close	16.00
Sales Surprise	2.34%	EPS Surprise	-6.58%	Sales Q/Q	4.84%	Earnings	May 08 BMO	Avg Volume	9.93M	Price	16.25
SMA20	18.47%	SMA50	18.31%	SMA200	46.78%	Trades		Volume	13,789,314	Change	1.56%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-08-24	Upgrade	JP Morgan	Underweight → Neutral	$14
Feb-12-24	Upgrade	Piper Sandler	Neutral → Overweight	$12 → $19
Jan-23-24	Upgrade	Jefferies	Hold → Buy	$10 → $14
Jan-03-24	Upgrade	Piper Sandler	Underweight → Neutral	$8 → $12
Dec-18-23	Initiated	HSBC Securities	Buy	$13
Nov-27-23	Upgrade	UBS	Neutral → Buy	$11 → $13
Jul-06-23	Upgrade	UBS	Sell → Neutral	$7 → $8
May-25-23	Initiated	Morgan Stanley	Equal-Weight	$10
May-18-23	Upgrade	Evercore ISI	In-line → Outperform
Jan-19-23	Downgrade	Jefferies	Buy → Hold	$10 → $12
Nov-14-22	Downgrade	JP Morgan	Neutral → Underweight	$11 → $10
Nov-04-22	Downgrade	UBS	Neutral → Sell
Oct-21-22	Resumed	Jefferies	Buy	$10
Aug-05-22	Upgrade	BofA Securities	Neutral → Buy	$10 → $13
Jun-14-22	Resumed	UBS	Neutral	$10
May-17-22	Upgrade	BofA Securities	Underperform → Neutral	$9
May-04-22	Downgrade	Piper Sandler	Neutral → Underweight	$11 → $7
Apr-05-22	Upgrade	Barclays	Equal Weight → Overweight	$11 → $13
Mar-25-22	Upgrade	Bernstein	Mkt Perform → Outperform	$11
Jan-27-22	Downgrade	Argus	Buy → Hold

Show Previous Ratings

May-09-24 11:37AM	Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2024 Earnings Call Transcript (Insider Monkey)
09:33AM	Affirm stock sinking, Good Buy or Goodbye: Market Domination (Yahoo Finance Video)
06:22AM	Teva and Medincell report positive data for TEV-749 in schizophrenia trial (Clinical Trials Arena)
May-08-24 04:29PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research) +12.83%
04:02PM	Teva Pharma's Turnaround Story: How A Key Win Helped It Clinch A Five-Year High (Investor's Business Daily)
02:10PM	Loading…
02:10PM	Teva Stock Powers Ahead as Schizophrenia News Offsets Mixed Earnings (Barrons.com)
02:00PM	Teva Pharmaceutical Industries (TEVA) Q1 2024 Earnings Call Transcript (Motley Fool)
12:51PM	Update: Teva Pharmaceutical Shares Rise After Reporting Higher Q1 Earnings, Revenue; 2024 Guidance Reaffirmed (MT Newswires)
11:56AM	TEVA Stock Earnings: Teva Pharmaceutical Indus Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
10:47AM	Teva Pharma Shoots To 5-Year High With Good News For Its Blockbuster Hopeful (Investor's Business Daily)
09:42AM	Teva Stock Is Powering Ahead as Schizophrenia News Offsets Mixed Earnings (Barrons.com)
09:30AM	Teva Pharmaceutical Industries (TEVA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
09:18AM	Sector Update: Health Care Stocks Lean Lower Pre-Bell Wednesday (MT Newswires)
08:53AM	Sector Update: Health Care (MT Newswires)
08:53AM	Teva Surges To 5-Year High On Maintained Outlook Despite Mixed First Quarter (Investor's Business Daily)
07:58AM	Loading…
07:58AM	Teva Pharmaceutical Industries Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed (MT Newswires)
07:55AM	REFILE-UPDATE 1-Teva Pharm Q1 profit misses estimates, revenue rises (Reuters)
07:28AM	Teva Pharmaceutical Industries Posts Narrower Loss In Q1 - Update (RTT News)
07:20AM	Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates (Reuters)
07:19AM	Teva Pharm Q1 profit falls short of estimates, revenue gains (Reuters)
07:00AM	Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook (Business Wire)
06:56AM	UPDATE 1-Teva and Medincell's schizophrenia drug meets main goal of late-stage study (Reuters)
06:36AM	Teva and Medincell's schizophrenia drug meets main goal of late-stage study (Reuters)
06:30AM	Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia (Business Wire)
May-07-24 04:30PM	Teva Earnings Are Soon. What Could Keep the Stock Gains Going. (Barrons.com)
12:45PM	20 States with the Highest Fertility Rates in the US (Insider Monkey)
May-03-24 05:58PM	A Week Of Fast-Moving Stocks Ahead: Disney, Toyota, Ferrari, Constellation (Investor's Business Daily)
09:15AM	Unlocking Q1 Potential of Teva Pharmaceutical Industries (TEVA): Exploring Wall Street Estimates for Key Metrics (Zacks)
May-02-24 06:30PM	Teva to Present at the 2024 Bank of America Healthcare Conference (Business Wire)
10:48AM	Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:30AM	Loading…
08:30AM	Tevas 2023 Healthy Future Report Showcases Renewed Sustainability Strategy and Ambitious Targets (Business Wire)
08:01AM	Q1 2024 Corcept Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
03:41AM	Corcept Therapeutics Inc (CORT) Q1 2024 Earnings Call Transcript Highlights: Strong Growth Amid ... (GuruFocus.com)
Apr-30-24 11:32AM	Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals (MT Newswires)
04:00AM	U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira (adalimumab) (Business Wire)
Apr-22-24 11:37AM	UPDATE 1-U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents (Reuters)
Apr-21-24 10:39AM	11 Best Low Price Pharma Stocks To Invest In (Insider Monkey)
Apr-16-24 05:43PM	Alvotech and Teva Announce U.S. FDA Approval of SELARSDI (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab) (Business Wire)
08:00AM	Tevas New Real-World Evidence Presented at the 2024 AAN Annual Meeting Confirms Effectiveness and Patient Satisfaction for HD Chorea with the 4-week Titration Kit for AUSTEDO® (deutetrabenazine) Tablets (Business Wire)
Apr-15-24 05:21PM	Israeli economy has proven to thrive despite crisis: Expert (Yahoo Finance Video)
Apr-11-24 08:30AM	Teva Confirms Efficacy and Safety of AJOVY® (fremanezumab) for the Prevention of Migraine With Results from Phase 3 Trial in China (Business Wire)
Apr-09-24 04:30PM	Teva to Host Conference Call to Discuss First Quarter 2024 Financial Results at 8 a.m. ET on May 8, 2024 (Business Wire)
Apr-06-24 01:00PM	New Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension at SIRS 2024 (Business Wire)
Apr-04-24 08:30AM	Teva and mAbxience Announce Strategic Global Licensing Agreement for Oncology Biosimilar Candidate (Business Wire)
Apr-03-24 05:21AM	3 No-Brainer Stocks to Buy With $600 Right Now (Motley Fool)
05:00AM	Biden and Senator Sanders to highlight efforts lower cost of asthma inhalers (Reuters)
Apr-01-24 02:01PM	UPDATE 1-Teva, Viatris win new chance to challenge J&J schizophrenia drug patent (Reuters)
11:52AM	Teva, Viatris win new chance to challenge J&J schizophrenia drug patent (Reuters)
08:30AM	Clinical Collaboration Agreement between Teva and Launch Therapeutics to Accelerate Development of Dual-Action Asthma Rescue Inhaler (ICS-SABA/TEV-248) Respiratory Program; Teva and Abingworth Enter Strategic Development Funding Agreement (Business Wire)
Mar-24-24 07:30PM	25 Countries with the Lowest Fertility Rates (Insider Monkey)
Mar-21-24 11:10PM	Q4 2023 Alvotech SA Earnings Call (Thomson Reuters StreetEvents)
Mar-18-24 03:06PM	Now That Two Inhaler Makers Are Capping Patient Costs, Will More Follow? (The Wall Street Journal)
Mar-08-24 05:00AM	EVP, CFO Eliyahu Kalif Sells 77,550 Shares of Teva Pharmaceutical Industries Ltd (TEVA) (GuruFocus.com)
Feb-26-24 02:19PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research)
09:58AM	TEVA Stock Pops 4% as Teva Receives FDA Approval (InvestorPlace)
07:00AM	Teva and Jiangsu Nhwa Forge Strategic Partnership to Promote Patient Access to AUSTEDO® in China (Business Wire)
Feb-23-24 08:15PM	Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira® (Business Wire)
Feb-20-24 08:30AM	Teva Presents New Data Supporting Safety, Tolerability and Target Engagement of Anti-TL1A (TEV-574) Antibody at the 2024 ECCO Annual Meeting (Business Wire)
04:43AM	UPDATE 2-Teva Pharm to stay as unified drugmaker, sees big interest in API business, says CEO (Reuters)
04:00AM	Teva Pharm to stay as unified generics, branded drugmaker -CEO says (Reuters)
Feb-16-24 09:04AM	Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2023 Earnings Call Transcript (Insider Monkey)
08:57AM	Q4 2023 Corcept Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-13-24 12:08AM	Decoding Teva Pharmaceutical Industries Ltd (TEVA): A Strategic SWOT Insight (GuruFocus.com)
Feb-12-24 10:18AM	Teva Pharmaceutical upgraded at Piper Sandler (Yahoo Finance Video) +7.49%
Feb-09-24 05:02PM	David Abrams Adjusts Portfolio, Meta Platforms Sees Notable Reduction (GuruFocus.com)
Feb-05-24 09:02AM	Chief Accounting Officer Amir Weiss Sells 31,766 Shares of Teva Pharmaceutical Industries Ltd (GuruFocus.com)
Feb-01-24 11:42AM	Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2023 Earnings Call Transcript (Insider Monkey)
Jan-31-24 04:05PM	Teva, GSK Put Up Bullish Fourth-Quarter Performances. Here's Where Novartis Fell Short. (Investor's Business Daily)
03:51PM	Teva Plans to Divest Drug Ingredients Business in Next Step of Strategic Shift (Barrons.com)
02:55PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research)
01:30PM	Teva Pharmaceutical Industries (TEVA) Q4 2023 Earnings Call Transcript (Motley Fool)
01:07PM	How Teva's CEO is implementing his 'pivot to growth' strategy (Yahoo Finance Video)
10:30AM	Teva Pharmaceutical Industries Ltd. (TEVA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
10:20AM	UPDATE 1-Teva Pharm sees lower 2024 profit after large Q4 beat (Reuters)
09:09AM	Teva Sinks On Lackluster Profit Outlook Despite Walloping Quarterly Projections (Investor's Business Daily)
08:10AM	Teva Pharma sees lower 2024 profit but higher sales after large Q4 beat (Reuters)
07:52AM	Teva Pharmaceutical Industries Ltd (TEVA) Reports Solid Growth in 2023 Earnings (GuruFocus.com)
07:20AM	Teva Pharma Guides FY24 Revenue Above Estimates; Intends To Divest API Business - Update (RTT News)
07:00AM	Teva Reports Growth in Fourth Quarter and Full Year 2023 (Business Wire)
06:32AM	Teva to divest active pharmaceutical ingredient business (Reuters)
06:20AM	UPDATE 2-Teva to divest active pharmaceutical ingredient business (Reuters)
06:00AM	Teva Announces Intention to Divest API Business as Part of Pivot to Growth Strategy (Business Wire)
Jan-28-24 12:42PM	50 Most Populated Countries in the World in 2024 (Insider Monkey)
Jan-26-24 09:15AM	Unveiling Teva Pharmaceutical Industries Ltd. (TEVA) Q4 Outlook: Wall Street Estimates for Key Metrics (Zacks)
Jan-25-24 09:40AM	Are Investors Undervaluing Teva Pharmaceutical Industries (TEVA) Right Now? (Zacks)
Jan-23-24 01:43AM	ExxonMobil, Duke Energy raised on improving sector valuations: 4 big analyst picks (Investing.com)
Jan-12-24 09:00AM	Why Big Pharma Led By Merck, Sanofi, Teva Are Pouring Billions Into A New Immunology Space (Investor's Business Daily)
Jan-10-24 05:21AM	3 No-Brainer Stocks to Buy With $20 Right Now (Motley Fool)
Jan-02-24 04:30PM	Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance at 8 a.m. ET on January 31, 2024 (Business Wire)
Dec-29-23 06:43PM	Corcept loses patent spat against Teva, shares tumble (Reuters)
06:34PM	UPDATE 2-Corcept loses patent spat against Teva, shares tumble (Reuters)
06:14PM	US judge rules in favor of Teva over patent spat with Corcept (Reuters)
Dec-28-23 04:30PM	Teva to Present at the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-26-23 10:51AM	HSBC Sees Opportunity in These 2 Biopharma Giants Ahead of the 2024 Elections (TipRanks)
Dec-22-23 10:54AM	GSK, Amneal, Kaléo delist patents from FDA's orange book (Yahoo Finance Video)
Dec-21-23 05:45AM	Here's Why Teva Pharmaceutical Industries Limited (TEVA) Rose in Q3 (Insider Monkey)
Dec-15-23 05:21AM	My 5 Largest Portfolio Holdings for 2024 (Motley Fool)
Dec-14-23 08:30AM	Teva and Biolojic Design Announce Exclusive License Agreement for the Development of a Therapeutic Antibody for Atopic Dermatitis and Asthma (Business Wire)
Dec-07-23 02:03PM	FTC warns pharma companies on excessive drug patenting (Yahoo Finance Video)
Dec-06-23 02:00AM	New Post Hoc Phase 3 Data Analysis Shows AJOVY® (fremanezumab) Reduced Migraine Attacks in Adults with Migraine and Co-morbid Obesity (Business Wire)

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kalif Eliyahu Sharon	EVP, Chief Financial Officer	Mar 06 '24	Sale	13.52	77,550	1,048,119	203,691	Mar 07 04:27 PM
Sabag Mark	EVP, International Markets	Mar 05 '24	Sale	13.52	100,000	1,352,090	382,590	Mar 07 04:12 PM
Daniell Richard	Exec. VP, European Commercial	Mar 05 '24	Sale	13.52	48,629	657,240	69,770	Mar 07 04:20 PM
Conway Vikki L	See "Remarks"	Mar 05 '24	Sale	13.52	1,427	19,286	15,219	Mar 07 04:16 PM
Daniell Richard	Exec. VP, European Commercial	Mar 04 '24	Sale	13.34	95,762	1,277,207	69,770	Mar 05 04:21 PM
Francis Richard D	President and CEO	Mar 04 '24	Sale	13.34	31,061	414,270	123,295	Mar 05 04:27 PM
Hughes Eric A	See "Remarks"	Mar 04 '24	Sale	13.34	8,045	107,299	16,855	Mar 05 04:16 PM
Conway Vikki L	See "Remarks"	Mar 04 '24	Sale	13.37	3,532	47,234	6,617	Mar 05 04:39 PM
Daniell Richard	Exec. VP, European Commercial	Feb 28 '24	Sale	13.12	20,599	270,176	69,770	Mar 01 06:43 AM
Drape Eric	Executive VP Global Operations	Feb 28 '24	Sale	13.12	9,815	128,734	9,701	Mar 01 06:45 AM
Conway Vikki L	See "Remarks"	Feb 28 '24	Sale	13.12	1,366	17,916	2,928	Mar 01 06:40 AM
Drape Eric	Executive VP Global Operations	Feb 16 '24	Sale	13.05	173,261	2,261,905	1	Feb 21 07:37 AM
Francis Richard D	President and CEO	Feb 15 '24	Sale	13.15	74,530	980,174	87,125	Feb 20 07:42 AM
Weiss Amir	Chief Accounting Officer	Feb 01 '24	Sale	12.37	31,766	392,955	10,676	Feb 05 07:49 AM
Kalif Eliyahu Sharon	EVP, Chief Financial Officer	Aug 07 '23	Sale	9.73	35,125	341,889	99,162	Aug 09 04:02 PM
Weiss Amir	Chief Accounting Officer	Aug 04 '23	Sale	9.92	1,981	19,658	42,442	Aug 07 04:15 PM
Hughes Eric A	See "Remarks"	Aug 01 '23	Sale	8.30	52,742	437,690	0	Aug 03 07:09 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Teva- Pharmaceutical Industries Ltd. ADR

Upgrade your FINVIZ experience